Even Healthcare secures fresh funding to grow Bengaluru hospital presence

A Bengaluru-based managed care startup has raised $50 million in a funding round led by Khosla Ventures, with Alpha Wave participating. The capital is reportedly earmarked for expanding the company’s hospital network in the city.

According to reports, the startup plans to grow its current facilities, which include two multispecialty hospitals, though specifics on timelines and locations remain undisclosed. The funding round follows earlier investments, including a $20 million raise earlier this year, bringing the total capital raised to over $120 million. The company has not shared its latest valuation but claims it has tripled since its previous fundraise 18 months ago.

The funding comes as the startup appears to be reorienting its business model. Reports from August indicated layoffs affecting 30-35% of its workforce, with the company scaling back its insurance operations to focus on hospital ownership. This pivot suggests a move away from its earlier approach, which combined preventive care, outpatient services, diagnostics, and insurance under a single managed care framework.

The startup’s model includes salaried doctors, whose compensation is reportedly tied to patient outcomes rather than revenue generation. It has also highlighted its use of AI tools for real-time case reviews and a dashboard tracking clinical metrics. The company claims its approach has led to lower unplanned readmissions and shorter hospital stays compared to industry averages, though these figures have not been independently verified.

However, its hospital expansion remains concentrated in Bengaluru, where it aims to strengthen its presence before considering other markets. Co-founder Mayank Banerjee has suggested this focus reflects a strategy to ensure strong service delivery in the city first.

The shift toward hospital ownership reflects broader industry dynamics, where vertical integration is seen as a way to control costs and improve patient outcomes. However, the approach is capital-intensive and faces challenges such as regulatory hurdles and real estate constraints, particularly in a competitive market like Bengaluru. The startup’s earlier valuation, reported at $300 million in October, may face pressure if expansion costs outpace revenue growth.

The startup’s reliance on salaried doctors and AI-driven protocols could also face scrutiny as it scales, particularly if patient volumes do not align with fixed costs. While the company claims its model has reduced hospitalizations and saved costs, the long-term sustainability of this approach remains unproven outside its current footprint.

Observers will be watching whether the startup’s Bengaluru expansion delivers on its promises or reveals limitations in its model. The next 18 months will be critical in determining whether its integrated care approach can compete with traditional hospitals and insurers at scale.

Sources: inc42.com